Vidarabine
Term · Oncology and biomedicine · MLC-T-ONC-017502
A nucleoside antibiotic isolated from the bacterium Streptomyces antibioticus with antineoplastic activity. Vidarabine inhibits DNA polymerase, resulting in the inhibition of DNA replication in tumor cells.
| Identifier | MLC-T-ONC-017502 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | ARA-A |
| Synonyms | Spongoadenosine; adenine arabinoside; araadenosine; Arabinosyladenine; Beta Ara-A |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-017502",
"term": "Vidarabine",
"field": "Oncology and biomedicine",
"definition": "A nucleoside antibiotic isolated from the bacterium Streptomyces antibioticus with antineoplastic activity. Vidarabine inhibits DNA polymerase, resulting in the inhibition of DNA replication in tumor cells.",
"abbreviation": "ARA-A",
"synonyms": [
"Spongoadenosine",
"adenine arabinoside",
"araadenosine",
"Arabinosyladenine",
"Beta Ara-A"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/vidarabine/"
}
Record 17,220 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.